Lifestyle
- Regular physical activity
- Weight management
- Stress reduction
Seek immediate medical attention if FBG < 2.8 mmol/L or > 13.9 mmol/L due to risk of severe hypoglycemia or hyperglycemia.
Fasting Blood Glucose · Nüchternblutzucker · FBG · Blutzucker
Fasting Blood Glucose quantifies the concentration of glucose in the blood after a fasting period, reflecting glucose metabolism and insulin function.
Fasting required; values may vary slightly based on lab standards.
Fasting Blood Glucose (FBG), also known as Nüchternglukose, measures the concentration of glucose in the blood after a period of fasting, typically 8-12 hours. It is a critical biomarker for assessing glucose metabolism and is used to diagnose and monitor diabetes mellitus. Researchers have found that FBG levels reflect the body's ability to maintain glucose homeostasis, which is primarily regulated by insulin. Clinically, FBG is significant in diagnosing diabetes and prediabetes, with elevated levels indicating impaired glucose regulation. It is also used to monitor the effectiveness of diabetes management strategies. Elevated FBG levels are associated with an increased risk of developing diabetes-related complications, such as neuropathy and cardiovascular diseases. In the context of athletic performance and biohacking, maintaining optimal FBG levels is crucial for metabolic efficiency and longevity. Athletes and biohackers often monitor FBG to optimize energy utilization and prevent metabolic disorders. However, FBG levels can be influenced by various factors, including stress, illness, and medication use. Researchers emphasize the importance of fasting before testing to obtain accurate results, as recent food intake can significantly alter glucose levels. Additionally, time-of-day variations and individual metabolic differences can affect FBG readings, necessitating consistent testing conditions for reliable monitoring.
Klinische Bedeutung
Elevated FBG levels indicate impaired glucose regulation, often associated with diabetes and prediabetes. Low FBG levels may suggest hypoglycemia, which can be due to excessive insulin or other metabolic conditions.
Progressively rising FBG suggests worsening glucose control, warranting lifestyle or medication adjustments. Retest in 4 weeks if outside optimal range.
Progressively falling FBG may indicate improved glucose regulation or risk of hypoglycemia.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant lifestyle changes, especially if on medication.
Test in the morning after an overnight fast for consistency.
Testing Frequency
Annually for healthy adults, more frequently if managing diabetes.
Correlated with
Current research suggests that reference ranges and optimal targets for fasting blood glucose (Nüchternglukose) in various populations, particularly in relation to sex-specific differences and confounding factors such as liver dysfunction, remain debated. Researchers have not yet established the precise impact of fasting blood glucose levels on the progression of conditions like hepatogenous diabetes. Additionally, clinical questions regarding the long-term implications of varying fasting glucose levels on neuropathy and cardiovascular risk remain unanswered.
1,491
Total Citations
13
Human/RCT
13.2
Avg. Influence
2026
Latest
Researchers found that glycated hemoglobin (HbA1c) is a reliable biomarker for diagnosing diabetes, reflecting long-term glycemic control. This study highlighted that elevated HbA1c correlates with an increased risk of diabetes complications, including coronary heart disease and stroke.
This study examined the prevalence and causes of peripheral neuropathy, highlighting that it affects 1% to 7% of the general population, particularly those over 50. Researchers found that diabetes mellitus is a common identifiable cause, and a comprehensive laboratory evaluation, including fasting blood glucose, is essential for diagnosis.
Researchers reviewed the effects of histidine supplementation, noting improvements in markers of glucose homeostasis, including fasting blood glucose. The study highlights the potential benefits of histidine for metabolic health, though further research is needed.
This review examined the triglyceride-glucose (TyG) index as a biomarker for insulin resistance and related disorders. Researchers observed that fasting blood glucose is one of the key components used to compute the TyG index, which is linked to cardiovascular disease.
This report discussed the dual role of serum ferritin as both an iron status measure and an inflammatory biomarker. Researchers suggested optimal ferritin levels could improve health outcomes, similar to fasting blood glucose adjustments.
Researchers analyzed fasting blood glucose levels across various diseases, finding significantly increased levels in 57 out of 64 conditions, including type 2 diabetes. The study indicates that elevated fasting blood glucose may be a common pathophysiological feature in diseased states.
This study explored hepatogenous diabetes (HD), which develops in patients with chronic liver disease. Researchers found that HD is associated with impaired glucose tolerance and a higher risk of complications compared to normoglycemic patients.
In this study, researchers evaluated serum SIRT1 levels as a potential biomarker for early Alzheimer's diagnosis. They found significantly lower levels in Alzheimer's patients compared to controls, indicating its diagnostic promise.
Researchers evaluated laboratory results in patients with spasmodic dysphonia, finding abnormal levels of fasting blood glucose among other markers. This study suggests that comprehensive laboratory evaluation can aid in diagnosing underlying conditions.
In this case report, researchers observed a 71-year-old female with low HbA1c despite high fasting blood glucose, attributed to hemolysis affecting test results. The findings suggest alternative measures like fructosamine may be beneficial in such cases.
Research publications about Nüchternglukose over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer